Results 171 to 180 of about 4,351,772 (298)
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu+11 more
wiley +1 more source
B Cells as a Host of Persistent Salmonella Typhimurium. [PDF]
Cruz-Cruz AD+4 more
europepmc +1 more source
B Lymphocyte Differentiation from Fetal Liver Stem Cells In89 Sr-Treated Mice [PDF]
Paul W. Kincade+3 more
openalex +1 more source
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani+14 more
wiley +1 more source
Polyclonal B cells acquire LCMV antigens in a GP1-dependent manner. [PDF]
Chamberlain G+8 more
europepmc +1 more source
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez+17 more
wiley +1 more source
CD27 on IgD-CD38-B Cells Mediates the Coprococcus-COPD Link. [PDF]
Gao Y, Chen L, Zhang J, Wen Z.
europepmc +1 more source
INDUCTION OF GUINEA PIG B-CELL LYMPHOKINE SYNTHESIS BY MITOGENIC AND NONMITOGENIC SIGNALS TO Fc, Ig, AND C3 RECEPTORS [PDF]
Sharon M. Wahl+2 more
openalex +1 more source